Empowering Innovators in Biopharma and Beyond

Join the growing list of organizations achieving their R&D goals with Elucidata.

Real Impact, Real Stories

Case study: Accelerated Target ID using ML-Ready data on Polly
Transforming Academic Core Facilities with Polly: AI-Driven Data Management for Efficiency, Collaboration, and Scalability
Read More
Case study: Accelerated Target ID using ML-Ready data on Polly
Six Months to Success: Accelerating AML Target-indication Assessment With Advanced Knowledge Graphs
Read More
Case study: Accelerated Target ID using ML-Ready data on Polly
Driving Breakthroughs in Clinical Research: Polly, the Only Multimodal AI-Ready Platform for New Product Development
Read More

Partnering with Innovators Across Biopharma

Voices of Impact

We were looking for public data on a tight deadline to make decisions on our back up targets for solid tumors. Elucidata was able to understand our relevance criteria, identify, and deliver high-quality harmonized data ahead of schedule. We are really happy with their deliveries and this partnership.

Ming 'Tommy' Tang
Director of Computational Biology, Immunitas Therapeutics

Data analysis is the biggest bottleneck for metabolomics research. Elucidata has worked directly with us to streamline our analysis pipeline, accelerating the pace of our research.

Dr. Russel Jones
Lead Investigator, Van Andel Institute

We really were pleasantly surprised because this tool [El-MAVEN] is really useful in fast analysis of tracer data. It allows us to really look at a broad set of targets so you are not limited anymore for data analysis. A data analyst of mine stepped up to me and said, "I can do now in 3 hours what used to take 4 days.

Bart Ghesquière
Head of Metabolomics Core Facility, VIB

Extremely impressed by Polly and its power to digest and integrate large datasets. The unique partnership that we have allows us to work hand-in-hand with software engineers and scientists to rapidly develop novel hypotheses that we can test in the lab.

Dr. Kate Yen
Founder & CEO, Auron Therapeutics

Data processing and scientific reporting of metabolomics data are crucial but also tedious. Polly’s range of applications helped our team in accelerating these processes significantly and effectively.

Dewakar Sangaraju
Senior Scientist, Genentech
Why Customers Choose Us

Utilized across 30+ Biopharma, biotech & Diagnostics partners today

3B+

Data points curated in 4 years

25k

Samples curated weekly

200+

Multi-modal data products (>10k samples each) developed

100+

Curators can ingest and label data at once

10X

Acceleration in efficiency

1000+

Hours of data wrangling saved across 20+ curation projects.

They’ve achieved it. So can you!

Let’s Get Started

Request a Demo